4//SEC Filing
Cummings Keith Lamont 4
Accession 0001746473-25-000011
CIK 0001746473other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 6:01 PM ET
Size
11.5 KB
Accession
0001746473-25-000011
Insider Transaction Report
Form 4
Cummings Keith Lamont
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-23+113,300→ 113,300 totalExercise: $11.14Exp: 2035-01-23→ Common Stock (113,300 underlying) - Award
Common Stock
2025-01-23+56,650→ 319,258 total
Footnotes (2)
- [F1]These are restricted stock units that vest in three substantially equal annual installments beginning January 16, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.
- [F2]1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.
Documents
Issuer
PLIANT THERAPEUTICS, INC.
CIK 0001746473
Entity typeother
Related Parties
1- filerCIK 0001809204
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 6:01 PM ET
- Size
- 11.5 KB